Monday, November 9, 2026

Oil-Mudslides Flooding South Sudan

Terry Swartzberg

May 28, 2018

The pipe was repaired, but the contaminant was left in the environment. Photo by: Nile Institute of Environmental Health.
Trigged by an oil spill and subsequent heavy rainfall, waves of oil and contaminants-soaked mud are rolling over South Sudanese villages and farmlands, reports the Nile Institute of Environmental Health (NIE-Health), one of the country’s leading environmental monitoring and reporting institutions. [caption id="attachment_4243" align="aligncenter" width="1000"]Oil workers attempting to contain the spill. Photo by: Nile Institute of Environmental Health. Oil workers attempting to contain the spill. Photo by: Nile Institute of Environmental Health.[/caption] The oil spill resulted from a bursting in December 2017 of a pipeline connecting Paloch and Adar, home to two of South Sudan’s most productive oil fields. The fields’ operators patched the pipeline and made a half-hearted attempt to bury and cover the spilled crude. The seasonal rainfall gripping South Sudan has transformed the oil residues into a viscously flowing mixture that is now making its poisonous way through the villages and farmlands. Alarmed at the loss of their fields and of their potable water, local communities are organizing to force the oil companies to take the measures so urgently need to quell this flood of contaminants. Leading Rights Groups Reveal How a South Sudan Oil Company Plays a Key Role in Prolonging Conflict
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com